Here - EWMA 2013

POSTER: DRESSINGS
Poster: Dressings
P 268
IMPLEMENTING A TWO-TIERED GLOBAL SCHEME FOR EVALUATING WOUND
DRESSING EFFICACY
John G. Thomas 1
1 West Virginia University (Morgantown, United States).
Aim: To compare silver wound dressing efficacy, we developed a standardized battery
of 5 organisms using 5 biochemical characteristics. Here, we, integrated a two tiered
strategy of 1) 10 global organisms, from different diseases and mechanisms of
resistance with 2) five methods of efficacy testing; by employing a coding system, a 12
digit classification could be obtained to compare dressing.
Methods: The organism battery included MRSA, VRE, and Staph aureus, and E. coli,
and Kleb pneumonia, EBBL+ and – for each and P. aeruginosa. Organisms were coded
from wounds, respiratory, and burn infections, WVUH, national and/or international
regions with known MICs. The 5 test battery included C-ZOI with and without
bioluminescent bacteria, flow cytometry, ratio of planktonic-biofilm phenotype, and
BARDOT, a laser scatter fingerprint. Organism description utilized 2 letters with results
coded as to Typical, Emerging, Atypical, with integers of 1, 2, or 3; patterns for both
organisms and test type allowed comparison and a searchable 12 digit number.
Results: Three different silver containing dressing (X/Y/Z) were assayed. Greatest
differences in organism coding were highlighted by 1)mechanism of resistance (ESBL)
2) and wound type (burns), followed by 3)Gram stain and organism, MRSA. The best
test battery for dressing differentiation focused on 1) FC and 2) bioluminescent C-ZOI.
The combined codes of 12 integers allowed for digital tracking and efficacy ranking.
Conclusion: To standardize silver dressing evaluations, we designed a 2 part
classification system based on multiple parameters, while building a unique, searchable
library.
P 269
The right choice of dressing makes the difference in the
treatment of malignant wounds
Poster: Dressings
Susanne Dufva 1 , Liselott Sahlberg 1 , Kerstin Granhäll Olson 1
1 Department of oncology, Karolinska University Hospital (Stockholm, Sweden).
Background: Malignant fungating wounds (MFW) result from cutaneous infiltration by
carcinogenic cells. Odour, exudate, pain, bleeding and infection are common symptoms
that add to the physical and psychological suffering of patients with MFW. The main
challenges are related to malodour, pain and difficulties in applying the wound dressings.
Patients are often treated by several different health care professionals, meeting a lack
of consistency in the protocol of care and limited time resources for dressing change.
Therefore it is important to standardise the treatment by providing an All-in-one
dressings for easy and quick application.
Aim: The aim of the study is to demonstrate the excellence of a new foam dressing in
the suppotive care of malignant fungating wounds on patients with mamma or head and
neck cancer.
Methods: Over a period of 4 weeks the dressing will be clinical evaluated on 5-10
patients with low to moderate exuding wounds. The endpoints are frequency of change,
ease of use, absorption capacity, patient experience of wound pain, wound odour, periwound
skin condition and overall satisfaction with the dressing.
Results: The results will be presented as case series including photos of the wound
conditions.
Conclusions: Todays standard of care is water, soap and a skin barrier on the
periwound area. Primarily a hydrofiber dressing is applied, seconded by a polyurethane
foam dressing with silicone boarder. This study will demonstrate the outcome when
choosing a new gelling foam dressing.
EWMA 2013
COPENHAGEN
15-17 May · 2013
Danish Wound
Healing Society
163